Stage
Seed VC | AliveAbout perora
perora develops a polymer-based fat-binding medical device as a novel platform for weight management and the treatment of obesity. perora´s technology approach is based on the development of peroral nutrient neutralizers (PNNs). PNNs are polymer compositions optimized for reducing the availability of the caloric load of food after ingestion. In combination with an innovative oral dosage form, a highly convenient and safe approach for weight management is being explored with the goal of providing a unique and effective treatment option.
perora Headquarter Location
Im Neuenheimer Feld 518
Heidelberg, D-69120,
Germany
Latest perora News
Sep 16, 2013
perora GmbH , a Heidelberg, Germany-based biotech company, raised a seed funding round of undisclosed amount. The backer was High-Tech-Gründerfonds . Incorporated in June 2013 and led by Dr. Dirk Vetter, Managing Director, and Dr. Kristina Schmidt, Chief Admin and Operations Officer, perora develops a polymer-based fat-binding medical device as a novel platform for weight management and the treatment of obesity. The company intends to use the funds to develop its s lead program, a medical device for the treatment of obesity and diabetes type II. FinSMEs
perora Patents
perora has filed 8 patents.
The 3 most popular patent topics include:
- Aquaculture
- Binary stars
- Dietary supplements
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/11/2015 | Dosage forms, Drug delivery devices, Pharmacokinetics, Vegetable oils, Fatty acids | Application | ||
Application Date | 8/11/2015 | ||||
|---|---|---|---|---|---|
Grant Date | |||||
Title | |||||
Related Topics | Dosage forms, Drug delivery devices, Pharmacokinetics, Vegetable oils, Fatty acids | ||||
Status | Application |